Nucleus Hybrid L24 Extended Duration Post Approval Study

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 14, 2015

Primary Completion Date

March 18, 2019

Study Completion Date

March 18, 2019

Conditions
Hearing Loss
Interventions
DEVICE

Nucleus Hybrid L24 Implant

Subjects have already been implanted with the Nucleus Hybrid L24 implant.

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Iowa

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

Midwest Ear Institute

OTHER

collaborator

University of Cincinnati

OTHER

collaborator

The Center for Hearing and Balance Disorders

AMBIG

collaborator

Ohio State University

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

Hearts for Hearing

OTHER

lead

Cochlear

INDUSTRY

NCT02379273 - Nucleus Hybrid L24 Extended Duration Post Approval Study | Biotech Hunter | Biotech Hunter